Found it in Seeking Alpha transcript from SPPI presentation at Merryll Lynch Health Care Conference. At the end of presentation, Ken Keller - Executive Vice President and Chief Operating Officer, made a slip in speaking about near term products from Spectrum and mentioned Marqibo.
Excerpt from Transcript - Buy the Rumor, Sell the News - this is a good stock IMO
Ken Keller - Executive Vice President and Chief Operating Officer
Thank you very much for your time. I really appreciate it. I think we are a company that really is just getting started. I mean what attracted me to come here, quite honestly, was three products on the market generating cash to really take these near-term cater that Dr. Rajesh spoke about the belinostat, the Marqibo taking the market very quickly, What’s beautiful about those products for us is from day one they dropped right into our existing infrastructure. The audience, it’s the hematology and transplant audience, that’s exactly who our reps call on today. So, we’ll be able to very effectively and productively bring those products to the market. I am looking forward to that opportunity. And when you look a little bit longer, the long-acting granulocyte colony-stimulating factor, very, very big market. Our team knows it well. This is a low-risk program. We’ll get on to Phase 2 very quickly. And so we are building a team and honestly just starting. So, thank you for the opportunity.